SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001824034-22-000002
Filing Date
2022-12-30
Accepted
2022-12-30 14:46:31
Documents
1
Effectiveness Date
2022-12-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8463
  Complete submission text file 0001824034-22-000002.txt   9501
Mailing Address 701 WEST MAIN STREET, SUITE 200 DURHAM NC 27701
Business Address 701 WEST MAIN STREET, SUITE 200 DURHAM NC 27701 919-667-2504
Avicenna Biosciences, Inc. (Filer) CIK: 0001824034 (see all company filings)

IRS No.: 851962440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-469305 | Film No.: 221501659